Nicotine

Generic Name
Nicotine
Brand Names
Habitrol, Nicoderm C-Q, Nicorelief, Nicorette, Nicotrol
Drug Type
Small Molecule
Chemical Formula
C10H14N2
CAS Number
54-11-5
Unique Ingredient Identifier
6M3C89ZY6R
Background

Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.

Indication

For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.

Associated Conditions
Withdrawal Nicotine
Associated Therapies
Smoking cessation therapy

Effect of the Electronic Cigarette on Withdrawal Symptoms

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-10-19
Last Posted Date
2019-03-27
Lead Sponsor
Queen Mary University of London
Target Recruit Count
51
Registration Number
NCT01454362
Locations
🇬🇧

Tobacco Dependence Research Unit, London, United Kingdom

Development of Positive Psychotherapy for Smoking Cessation

First Posted Date
2011-10-14
Last Posted Date
2015-03-18
Lead Sponsor
Brown University
Target Recruit Count
66
Registration Number
NCT01451814
Locations
🇺🇸

Center for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island, United States

A Study on the Effects of Two Nicotine Replacement Products on Tooth Staining

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-09-27
Last Posted Date
2012-07-10
Lead Sponsor
McNeil AB
Target Recruit Count
200
Registration Number
NCT01440985
Locations
🇮🇪

Dental School and Hospital, University College of Cork, Wilton, Cork, Ireland

Nicotine Patch for Marijuana Withdrawal

Phase 4
Completed
Conditions
Interventions
First Posted Date
2011-07-22
Last Posted Date
2015-04-30
Lead Sponsor
Southern Illinois University Carbondale
Target Recruit Count
127
Registration Number
NCT01400243
Locations
🇺🇸

Southern Illinois University, Carbondale, Illinois, United States

Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine Gum

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-06-07
Last Posted Date
2012-07-10
Lead Sponsor
McNeil AB
Target Recruit Count
346
Registration Number
NCT01368016
Locations
🇸🇪

Clinical Pharmacology, McNeil AB, Lund, Sweden

🇸🇪

Karolinska Trial Alliance (KTA), University Hospital Huddinge, Stockholm, Sweden

Effects of Contingency Management and Nicotine Replacement Therapy on Youth Smoking

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-05-25
Last Posted Date
2016-05-13
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
60
Registration Number
NCT01359709
Locations
🇺🇸

University California, Los Angeles, Los Angeles, California, United States

Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-03-24
Last Posted Date
2012-07-10
Lead Sponsor
McNeil AB
Target Recruit Count
50
Registration Number
NCT01321931
Locations
🇸🇪

McNeil AB Clinical Pharmacology R&D, Lund, Sweden

Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2011-02-15
Last Posted Date
2012-04-23
Lead Sponsor
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Target Recruit Count
257
Registration Number
NCT01296698
Locations
🇺🇸

Stark Pharmacy, Overland Park, Kansas, United States

🇺🇸

T.B. Bond Pharmacy, Hillsboro, Texas, United States

🇺🇸

Medicap Pharmacy, Clarksdale, Mississippi, United States

and more 14 locations

Single-dose Pharmacokinetics of Oral Nicotine Replacement Products

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2010-10-26
Last Posted Date
2011-10-06
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
40
Registration Number
NCT01228617
Locations
🇸🇪

Clinical Trial Unit, Clinical Research and Trial Centre, Lund, Sweden

Nicotinic Modulation of the Default Network

First Posted Date
2010-10-19
Last Posted Date
2019-08-19
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
21
Registration Number
NCT01223404
Locations
🇺🇸

National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland, United States

🇺🇸

Maryland Psychiatric Research Center, Baltimore, Maryland, United States

© Copyright 2024. All Rights Reserved by MedPath